Ivan Monteleone Selected Research

Ivan Monteleone Research Topics

Disease

19	Inflammation (Inflammations) 03/2020 - 09/2003
15	Colitis 01/2022 - 12/2006
14	Crohn Disease (Crohn's Disease) 01/2022 - 03/2005
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 02/2004
7	Ulcerative Colitis 01/2022 - 03/2005
6	Neoplasms (Cancer) 01/2021 - 10/2011
6	Celiac Disease (Celiac Sprue) 01/2019 - 09/2003
5	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 09/2012
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2011
3	Fibrosis (Cirrhosis) 03/2020 - 04/2016
3	Atrophy 01/2019 - 10/2009
3	Infections 01/2014 - 03/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 05/2011
2	Colitis-Associated Neoplasms 10/2011 - 10/2011
2	Hyperplasia 05/2011 - 10/2009
1	Neoplastic Processes 01/2021
1	Carcinogenesis 10/2019
1	Skin Neoplasms (Skin Cancer) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 02/2017
1	Dysbiosis 01/2016
1	Fatty Liver 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Necrosis 08/2015
1	ST Elevation Myocardial Infarction 10/2013
1	Acute Coronary Syndrome 10/2013

Drug/Important Bio-Agent (IBA)

18	CytokinesIBA 01/2022 - 03/2005
6	Antisense OligonucleotidesIBA 05/2021 - 12/2006
5	GED0301IBA 05/2021 - 04/2012
5	Pharmaceutical PreparationsIBA 07/2020 - 10/2019
5	Proteins (Proteins, Gene)FDA Link 03/2020 - 11/2005
5	Therapeutic UsesIBA 03/2020 - 12/2006
5	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019 - 07/2011
5	Glutens (Glutelin)IBA 01/2019 - 09/2003
5	interleukin-21 (interleukin 21)IBA 10/2011 - 03/2005
4	6-formylindolo(3,2-b)carbazoleIBA 01/2019 - 07/2011
4	Sulfonic AcidsIBA 02/2017 - 12/2006
4	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2012 - 03/2004
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2006 - 02/2004
3	LigandsIBA 01/2019 - 07/2012
3	Interleukin-22 (IL-22)IBA 01/2019 - 07/2011
3	Dextran SulfateIBA 02/2017 - 07/2011
3	Transforming Growth Factor beta (TGF-beta)IBA 03/2012 - 03/2004
3	InterleukinsIBA 03/2012 - 08/2010
2	AcidsIBA 01/2022 - 03/2012
2	Messenger RNA (mRNA)IBA 01/2021 - 08/2015
2	OligonucleotidesIBA 07/2020 - 01/2018
2	CollagenIBA 03/2020 - 01/2018
2	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2020 - 08/2015
2	RafoxanideIBA 01/2020 - 10/2019
2	Poly I-CIBA 01/2019 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2011
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2016 - 11/2012
2	GhrelinIBA 01/2014 - 12/2013
2	2-methoxy-5-amino-N-hydroxybenzamideIBA 09/2012 - 10/2011
2	Mesalamine (Mesalazine)FDA LinkGeneric 09/2012 - 10/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2011 - 05/2011
2	Interferon-gamma (Interferon, gamma)IBA 08/2010 - 03/2005
2	NF-kappa B (NF-kB)IBA 11/2005 - 02/2004
1	Deubiquitinating EnzymesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Fragile X Mental Retardation ProteinIBA 01/2021
1	osteoblast cadherinIBA 03/2020
1	GlycolipidsIBA 03/2020
1	Toll-Like Receptor 4IBA 03/2020
1	TLR4 antagonist FP7IBA 03/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Albendazole (Albenza)FDA Link 01/2020
1	Calcibiotic Root Canal SealerIBA 10/2019
1	Mutant Proteins (Protein, Mutant)IBA 10/2019
1	ProgranulinsIBA 10/2019
1	Dextrans (Dextran)FDA Link 05/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2019
1	ursodoxicoltaurineIBA 01/2019
1	Mucin-2IBA 01/2019
1	GelatinIBA 01/2019
1	Food Additives (Food Additive)IBA 01/2019
1	maltodextrinIBA 01/2019
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019
1	AMP-Activated Protein KinasesIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Chemokine CCL20IBA 05/2017
1	SaltsIBA 02/2017
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 02/2017
1	Sodium Chloride FDA LinkGeneric 02/2017
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 04/2016
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	ChemokinesIBA 01/2016
1	Natural Killer Cell ReceptorsIBA 01/2016
1	Infliximab (Remicade)FDA Link 08/2015
1	Granzymes (Granzyme)IBA 06/2014
1	Immunoglobulin A (IgA)IBA 06/2014
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2014
1	oxidized low density lipoproteinIBA 10/2013

Therapy/Procedure

6	Therapeutics 05/2021 - 05/2011
1	Drug Therapy (Chemotherapy) 01/2020